Is iRhythm Technologies Inc (IRTC) overvalued? · rev $747.1M
iRhythm Technologies Inc (IRTC) is a medical devices company listed on US.
This page asks whether iRhythm Technologies Inc (IRTC) looks expensive on cached numbers — not a short thesis.
Latest reported IRTC revenue for 2025-12-31 was $747.1M. Net income was -$44.6M. Revenue was up 26.2% from 2024-12-31 to 2025-12-31. IRTC currently screens at market cap $4.55B.
IRTC currently screens at market cap $4.55B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next IRTC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the IRTC stock page for the full model, not this heading.
Not investment advice.